PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New research reveals unexpected biological pathway in glaucoma

Study is first to pinpoint the precise anatomical location where vision loss appears to occur in glaucoma

2011-01-04
(Press-News.org) (Baltimore, MD) — In a study published today in the Proceedings of the National Academy of Sciences (Early Edition ahead of print), a team of researchers from the Kennedy Krieger Institute and four collaborating institutions, identified a new and unexpected biological pathway that appears to contribute to the development of glaucoma and its resulting vision loss.

Prior research has suggested that the optic nerve head, the point where the cables that carry information from the eye to the brain first exit the eye, plays a role in glaucoma. In this study, researchers report a series of findings that offer novel insights into cellular and molecular mechanisms operating at the optic nerve head in two mouse models of glaucoma. Most notably, they discovered that at a specific location within the optic nerve head, there is a unique class of cells called astrocytes that demonstrate properties that appear to make them a critical factor in the visual blinding that occurs in glaucoma.

Further, at this same site, researchers found abnormal forms of a protein called gamma synuclein that is similar to abnormal forms of alpha synuclein, a related protein known for its key role in cell loss in Parkinson's disease. The findings suggest that a biological process similar to Parkinson's disease unfolds in glaucoma at the specific anatomical location pinpointed in this study for the first time.

Finally, researchers discovered that at this anatomical location, there is a surprising process whereby astrocytes remove the debris of neurons, the cells that die in neurodegenerative disorders such as glaucoma. It is likely that this newly discovered process involving removal of the debris of one cell by a neighboring cell is important not only in glaucoma and Parkinson's disease, but also for many neurodegenerative diseases.

"These findings are very exciting because they give us several novel targets for future interventions," said Dr. Nicholas Marsh-Armstrong, senior study author and a research scientist at Kennedy Krieger Institute. "I believe these findings put us on the cusp of discovering a treatment for glaucoma that may also have relevance for a number of other neurodegenerative diseases."

Future studies will examine this novel pathway and molecular/cellular mechanism to understand precisely what steps go awry in glaucoma and what can be controlled pharmacologically to identify interventions that slow the disease progression.

Dr. Marsh-Armstrong and other scientists at Kennedy Krieger Institute collaborated on this study with colleagues at the Johns Hopkins University School of Medicine, University of California at San Diego, Cardiff University in England, and the University of Murcia in Spain.

###

This research was principally supported by the Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation, with additional grant funding provided in part by the International Retinal Research Foundation and the National Eye Institute of the National Institutes of Health.

About Glaucoma

Glaucoma is a neurodegenerative disorder that causes blindness by damaging the optic nerve, which sends signals from the eye to the brain. It affects more than 60 million people and is the second leading cause of blindness worldwide. While older individuals are at higher risk for the disease, babies and children are also susceptible to glaucoma, especially those with certain neurological disorders.

About the Kennedy Krieger Institute

Internationally recognized for improving the lives of children and adolescents with disorders and injuries of the brain and spinal cord, the Kennedy Krieger Institute in Baltimore, MD serves more than 16,000 individuals each year through inpatient and outpatient clinics, home and community services and school-based programs. Kennedy Krieger provides a wide range of services for children with developmental concerns mild to severe, and is home to a team of investigators who are contributing to the understanding of how disorders develop while pioneering new interventions and earlier diagnosis. For more information on Kennedy Krieger Institute, visit www.kennedykrieger.org.

About the Glaucoma Research Foundation

Located in San Francisco, the Glaucoma Research Foundation is the nation's most experienced foundation dedicated solely to glaucoma research and education. In addition to funding innovative research like the Catalyst For a Cure research consortium and its Shaffer Grants for Innovative Glaucoma Research, Glaucoma Research Foundation provides free education material, including the definitive reference for newly diagnosed patients, Understanding and Living with Glaucoma (available in both English and Spanish editions); brochures serving those at highest risk, including African-Americans and Latinos; and a toll free phone, 800-826-6693, staffed during office hours with an information specialist to answer questions about glaucoma. For more information, please visit www.glaucoma.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Wastewater treatment lowers pathogen levels

2011-01-04
Madison, WI DECEMBER 30, 2010 – A recent study by a team of researchers at the University of Arizona has tracked the incident of pathogens in biosolids over a 19 year period in one major U.S. city. In the same study, the researchers also analyzed pathogen levels in biosolids at 18 wastewater treatment plants in the United States. Their analysis indicates pathogens levels have dropped since the implementation of federal regulations on treating sewage in 1993. These treatment guidelines have proven to be extremely effective with 94% to 99% of all pathogens in biosolids ...

Advancements in fertility preservation provide oncology patients new options

2011-01-04
ROCHESTER, Minn. -- Many young people who've just learned that they have cancer also are told that the therapies that may save their lives could rob them of their ability ever to have children. Infertility caused by chemotherapy and radiation affects a sizable population: Of the 1.5 million people diagnosed with cancer in 2009, nearly 10 percent were still in their reproductive years. The good news, according to an article in the January issue of Mayo Clinic Proceedings (http://www.mayoclinicproceedings.com ), is that techniques to harvest and store reproductive cells ...

Anti-bullying program reduces malicious gossip on school playgrounds

2011-01-04
Elementary school students who participated in a three-month anti-bullying program in Seattle schools showed a 72 percent decrease in malicious gossip. The study, led by the University of Washington, is the first to show that the widely-used Steps to Respect bullying prevention program can curb children's gossip, an element of playground culture often seen as harmless but capable of causing real harm. "Gossip is an element of bullying, and it can lead to physical bullying," said Karin Frey, a UW research associate professor of educational psychology. "Kids will tell ...

Protein wields phosphate group to inhibit cancer metastasis

Protein wields phosphate group to inhibit cancer metastasis
2011-01-04
HOUSTON - By sticking a chemical group to it at a specific site, a protein arrests an enzyme that may worsen and spread cancer, an international research team led by scientists at The University of Texas MD Anderson Cancer Center reports in the January issue of Nature Cell Biology. In addition to highlighting a novel anti-cancer pathway, the team found that the same deactivation of the enzyme called EZH2 is necessary for the formation of bone-forming cells from the stem cells that make them and other tissues. "EZH2 is overexpressed in aggressive solid tumors and tied ...

Mothers key to college-age women receiving HPV vaccine

2011-01-04
COLUMBUS, Ohio -- Even after young women reach adulthood, their mothers can play a key role in convincing them to receive the human papillomavirus (HPV) vaccine, new research suggests. A study found that college-aged women were more likely to say they had received the HPV vaccine if they had talked to their mother about it. "Mothers talking to their daughters were an important factor in whether young women were vaccinated," said Janice Krieger, lead author of the study and assistant professor of communication at Ohio State University. "It is an encouraging finding, ...

Some banks help keep mortgage holders out of default, studies find

2011-01-04
COLUMBUS, Ohio – While the nation's foreclosure crisis has focused blame on bad loan practices by some lenders, new research shows how some banks may have actually reduced the default risk of their homebuyers. Researchers found that low-income homeowners who received a mortgage from a local lender were less likely to default on their loans than are those who borrowed from a more distant bank or mortgage company. Even if two similar homeowners received the same home loan, with the same interest rate, the one who got the loan at the local lender might be better off in ...

Parallels between cancers, infection suppression reported

2011-01-04
Tiny parasitoid wasps can play an important role in controlling the populations of other insect species by laying their eggs inside the larvae of these species. A newly hatched wasp gradually eats the host alive and takes over its body. The host insect is far from defenseless, however. In Drosophila (fruit flies), larvae activate humoral immunity in the fat body and mount a robust cellular response that encapsulates and chokes off the wasp egg. New research by Dr. Shubha Govind, professor of biology at The City College of New York, and colleagues reveals parallels ...

Care of late-preterm preemies may be insufficient

2011-01-04
MAYWOOD, Ill. – In the last 15 years the U.S has seen a sharp increase in the number of babies born as late-preterm infants, between 34 and 37 weeks' gestation. This is approximately 400,000 children each year, comprising over 70 percent of all preterm births. Often, late-preterm infants are treated the same as full-term infants since they are commonly a similar size and weight. Growing research is showing that this can be detrimental to a late-preterm infant's health and frequently results in readmission to the hospital within the first month of life. "Late-preterm infants ...

ATS issues statement on the treatment of pulmonary fungal infections

2011-01-04
The American Thoracic Society has released a new official clinical policy statement on the treatment of fungal infections in adult pulmonary and critical care patients. The statement replaces ATS guidelines published in 1988, and takes into account new medications and treatment approaches, as well as provides an overview of emerging fungi. The statement appears in the January 1, 2011, issue of the American Journal of Respiratory and Critical Care Medicine. Pulmonary fungal infections occur commonly in patients whose immune systems are compromised, either by an underlying ...

U-M study: Kids frequently exposed to medical imaging procedures that use radiation

2011-01-04
ANN ARBOR, Mich. — The rapid growth in use of medical diagnostic imaging, such as CT scans, has led to widespread concern about radiation exposure in adults and the potential for future cancer risk in patients undergoing these tests. A new study led by University of Michigan researchers now shows that kids also frequently receive these types of imaging procedures during their routine clinical care, and highlights the importance of initiatives to ensure that those tests being performed are necessary and use the lowest possible doses of radiation. "Our findings indicate ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] New research reveals unexpected biological pathway in glaucoma
Study is first to pinpoint the precise anatomical location where vision loss appears to occur in glaucoma